Compare TPCS & YI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | TPCS | YI |
|---|---|---|
| Founded | 1956 | 2010 |
| Country | United States | China |
| Employees | N/A | N/A |
| Industry | Metal Fabrications | Retail-Drug Stores and Proprietary Stores |
| Sector | Industrials | Consumer Staples |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 40.9M | 38.1M |
| IPO Year | N/A | N/A |
| Metric | TPCS | YI |
|---|---|---|
| Price | $4.66 | $3.09 |
| Analyst Decision | | |
| Analyst Count | 0 | 0 |
| Target Price | N/A | N/A |
| AVG Volume (30 Days) | ★ 29.6K | 13.9K |
| Earning Date | 11-13-2025 | 12-17-2025 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | $33,564,000.00 | ★ $1,908,028,152.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | N/A | N/A |
| Revenue Growth | ★ 1.15 | N/A |
| 52 Week Low | $2.05 | $2.80 |
| 52 Week High | $6.25 | $11.35 |
| Indicator | TPCS | YI |
|---|---|---|
| Relative Strength Index (RSI) | 54.23 | 34.46 |
| Support Level | $4.24 | $2.80 |
| Resistance Level | $4.74 | $3.79 |
| Average True Range (ATR) | 0.26 | 0.21 |
| MACD | 0.04 | -0.04 |
| Stochastic Oscillator | 76.14 | 25.04 |
Techprecision Corp manufactures metal fabricated and machined precision components and systems. It offers a full range of services required to transform raw materials into precision finished products. The company's products are used in markets including defense, aerospace, nuclear, medical, and precision industries. All of its operations and customers are located in the United States. The company have two wholly owned subsidiaries that are each reportable segments: Ranor and Stadco. Each reportable segment focuses on the manufacture and assembly of specific components. It derives maximum revenue from Ranor segment.
111 Inc operates an integrated online and offline platform in the healthcare ecosystem in China, whereby the Group is engaged in the sales of medical and wellness products through online retail and wholesale pharmacies and offline retail pharmacies, as well as the provision of certain value-added services, such as online consultation services and e-prescription services to consumers in the People's Republic of China. The company has two operating segments: the B2C segment and B2B segment whereby the B2C business represents revenue generated from individual consumers while the B2B business represents revenue generated from corporate customers. It derives a majority of its revenue from the B2B segment.